NextCure, Inc.
NXTC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001661059
In the last 90 days, NextCure, Inc. insiders filed 2 open-market purchases and 1 sale; 30 institutions reported holding it in 13F filings for Q2 2026, worth $2.78M in total; no superinvestor holds it.
Q1 2024 vs. Q4 2023
How the institutions holding NextCure, Inc. changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Q1 2024 | Change |
|---|---|---|---|
| Holders | 43 | 47 | +4 |
| Shares | 13.3M | 16.1M | +2.80M (+21.0%) |
| Value | $15.3M | $36.0M | +$20.7M (+135.7%) |
New holders (6)
Institutions that held NextCure, Inc. at the end of Q1 2024 but not at the end of Q4 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Logos Global Management LP | 1,925,000 | $4.29M | 0.45% |
| Affinity Asset Advisors, LLC | 1,359,037 | $3.03M | 0.49% |
| Assenagon Asset Management S.A. | 426,717 | $951.6K | 0.00% |
| Schonfeld Strategic Advisors LLC | 393,240 | $876.9K | 0.01% |
| Cardiff Park Advisors, LLC | 262,000 | $584.3K | 0.06% |
| Hudson Bay Capital Management LP | 203,800 | $454.5K | 0.00% |
Sold out (2)
Institutions that held NextCure, Inc. at the end of Q4 2023 and filed for Q1 2024 without it.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| Virtu Financial LLC | 26,550 | $30.0K |
| Franklin Resources Inc | 19,588 | $22.3K |